NCT06262295View on ClinicalTrials.gov

A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

September 14, 2028

Study Completion Date

September 14, 2028

Conditions
Pacemaker
Trial Locations (1)

38700

RECRUITING

Chu de Grenoble - Hopital Michallon, La Tronche

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

French Cardiology Society

OTHER

NCT06262295 - A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP | Biotech Hunter | Biotech Hunter